The Role of Cytokines in the Pathogenesis of Pneumonia

  • M. J. Schultz
  • S. J. H. van Deventer
  • T. van der Poll
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1998)


Bacterial pneumonia is a major cause of morbidity and mortality worldwide, despite the armamentarium of antibacterial agents, advanced diagnostic technologies and sophisticated, sometimes aggressive treatments used in intensive care facilities. In developing countries community-acquired pneumonia causes ten times as many deaths as all infectious diseases together [1]. Pneumonia is the second most frequent cause of hospital-acquired infection in the United States [2].


Colony Form Unit Pleural Fluid Pneumococcal Pneumonia Lung Homogenate Tuberculous Pleural Effusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    British Thoracic Society Research Committee (1987) Community-acquired pneumonia in adults in British hospitals in 1982–1983: A survey of aetiology, mortality, prognostic factors and outcome. Q J Med 62: 195–220Google Scholar
  2. 2.
    Horan T, Culver D, Jarvis W (1988) Pathogens causing nosocomial infections. Antimicrob Newsletter 5: 65–67CrossRefGoogle Scholar
  3. 3.
    Davies J (1994) Inactivation of antibiotics and the dissemination of resistance genes. Science 264: 375–382PubMedCrossRefGoogle Scholar
  4. 4.
    Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365–375PubMedCrossRefGoogle Scholar
  5. 5.
    Tsai WC, Strieter RM, Zisman DA, et al (1997) Nitric Oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 65: 1870–1875PubMedGoogle Scholar
  6. 6.
    Hopken UE, Lu B, Gerard NP, Gerard C (1996) The C5a chemoattractant receptor mediates mucosal defense to infection. Nature 383: 86–89PubMedCrossRefGoogle Scholar
  7. 7.
    Winkelstein JA (1981) The role of complement in the host’s defense against Streptococcus pneumoniae. Rev Infect Dis 3: 289–297PubMedCrossRefGoogle Scholar
  8. 8.
    Pajkrt D, van der Poll T, van Deventer SJH (1997) Inflammatory responses during human endotoxemia. In: Vincent JL (ed) 1997 Yearbook of intensive care and emergency medicine. Springer-Verlag, Berlin, Heidelberg, pp 14–30Google Scholar
  9. 9.
    Van der Poll T, Lowry SF (1995) Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3: 1–12PubMedGoogle Scholar
  10. 10.
    Dinarello CA (1996) Biological basis for interleukin 1 in disease. Blood 87: 2095–2147PubMedGoogle Scholar
  11. 11.
    Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM, Miller R (1995) Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 155: 5038–5045PubMedGoogle Scholar
  12. 12.
    Van der Poll T, Levi M, Hack CE, et al (1994) Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179: 1253–1259PubMedCrossRefGoogle Scholar
  13. 13.
    Moore KW, O’Garra A, de Waal Malefyt R, Vierra P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11: 165–190Google Scholar
  14. 14.
    Kragsbjerg P, Vekerfors T, Holmberg H (1993) Serum levels of interleukin 6, tumor necrosis factor alpha, interferon gamma and C-reactive protein in adults with community-acquired pneumonia. Serodiagn Immunoth Infect Disease 5: 156–160CrossRefGoogle Scholar
  15. 15.
    Kragsbjerg P, Jones I, Vikerfors T, Holmberg H (1995) Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax 50: 1253–1257PubMedCrossRefGoogle Scholar
  16. 16.
    Puren AJ, Feldman C, Savage N, Becker P), Smith C (1995) Patterns of cytokine expression in community-acquired pneumonia. Chest 107: 1342–1349PubMedCrossRefGoogle Scholar
  17. 17.
    Moussa K, Michie HJ, Cree IA, et al (1994) Phagocyte function and cytokine production in community-acquired pneumonia. Thorax 49: 107–111PubMedCrossRefGoogle Scholar
  18. 18.
    Silva-Mejias C, Gamboa-Antinolo F, Lopez-Cortez LF, Cruz-Ruiz M, Pachon J (1995) Interleukin 1 beta in pleural fluids of different etiologies. Its role as inflammatory mediator in empyema. Chest 108: 942–945PubMedCrossRefGoogle Scholar
  19. 19.
    Broaddus VC, Hebert CA, Vitangcol RV, Hoeffel JM, Bernstein MS, Bylan AM (1992) Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 146: 825–830PubMedGoogle Scholar
  20. 20.
    Dehoux MS, Boutten A, Ostinelli J, et al (1994) Compartmentalized cytokine production within human lung in unilateral pneumonia. Am J Resp Crit Care Med 150: 710–716PubMedGoogle Scholar
  21. 21.
    Boutten A, Dehoux MS, Seta N, et al (1996) Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 153: 336–342PubMedGoogle Scholar
  22. 22.
    Schutte H, Lohmeyer J, Rosseau S, et al (1996) Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 9: 1858–1867PubMedCrossRefGoogle Scholar
  23. 23.
    Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. 88: 1747–1754Google Scholar
  24. 24.
    Huang ZB, Eden E (1993) Effect of corticosteroids on IL-lß and TNF alpha release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 104: 751–755PubMedCrossRefGoogle Scholar
  25. 25.
    Takashima K, Tateda K, Matsumoto T, Iizawa Y, Nakao M, Yamaguchi K (1997) Role of tumor necrosis factor alpha in the pathogenesis of pneumococcal pneumonia in mice. Infect Immun 65: 257–260PubMedGoogle Scholar
  26. 26.
    Van der Poll T, Keogh CV, Buurman WA, Lowry SF (1997) Passive immunization against tumor necrosis factor alpha impairs host defense during pneumococcal pneumonia. Am J Resp Crit Care Med 155: 603–608PubMedGoogle Scholar
  27. 27.
    Laichalk LL, Kunkel SL, Strieter RM, Danforth JM, Bailie MB, Standiford TJ (1996) Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 64: 5211–5218PubMedGoogle Scholar
  28. 28.
    Brieland JK, Remick DG, Freeman PJ, Hurley MC, Fontane JC, Engleberg NC (1995) In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect Immun 63: 3253–3258PubMedGoogle Scholar
  29. 29.
    Chen W, Havell EA, Harmsen AG (1992) Importance of endogenous tumor necrosis factor alpha and interferon gamma in host resistence against Pneumocystis carinii infection. Infect Immun 60: 1279–1284PubMedGoogle Scholar
  30. 30.
    Amura C, Fontan PA, Sanjuan N, Sordelli DO (1994) The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model. Clin Immunol Immunopath 2: 261–266CrossRefGoogle Scholar
  31. 31.
    Greenberger MJ, Strieter RM, Kunkel SL, et al (1996) Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 173: 159–165PubMedCrossRefGoogle Scholar
  32. 32.
    Van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF (1997) Interleukin-6 gene deficient mice show impaired defense against Streptococcal pneumonia. J Infect Dis 176: 439–444PubMedCrossRefGoogle Scholar
  33. 33.
    Rubins JB, Pomeroy C (1997) Role of gamma interferon in the pathogenesis of bacteremic pneu-mococcal pneumonia. Infect Immun 65: 2975–2977PubMedGoogle Scholar
  34. 34.
    Greenberger MJ, Kunkel SL, Strieter RM, et al (1996) IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 157: 3006–3012PubMedGoogle Scholar
  35. 35.
    Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ (1995) Neu-tralizing of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155: 722–729PubMedGoogle Scholar
  36. 36.
    Van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF (1996) Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174: 994–1000PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • M. J. Schultz
  • S. J. H. van Deventer
  • T. van der Poll

There are no affiliations available

Personalised recommendations